Apyx Medical (NASDAQ:APYX) just reported results for the second quarter of 2024. Apyx Medical reported earnings per share of -19 cents. This was above the analyst estimate for EPS of -20 cents.
Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today ...
CLEARWATER, Fla. (AP) — CLEARWATER, Fla. (AP) — Apyx Medical Corporation (APYX) on Friday reported a loss of $4.7 million in its third quarter. On a per-share basis, the Clearwater ...
CLEARWATER, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical” or the “Company”), the manufacturer of a proprietary helium plasma and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback